Ligand Pharmaceuticals, Inc.

( )
LGND PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -2.04%128.550.0%$1289.77m
OCGNOcugen, Inc. -1.91%10.260.0%$1230.03m
NVAXNovavax, Inc. -3.13%177.8792.9%$698.67m
AMGNAmgen, Inc. 0.00%223.941.3%$548.96m
VRTXVertex Pharmaceuticals, Inc. -0.93%206.501.9%$514.03m
REGNRegeneron Pharmaceuticals, Inc. -0.48%444.582.7%$500.77m
GILDGilead Sciences, Inc. 0.10%62.811.0%$480.52m
ILMNIllumina, Inc. -0.34%415.003.5%$474.87m
ALXNAlexion Pharmaceuticals, Inc. 0.00%148.192.0%$341.53m
BIIBBiogen, Inc. 0.00%266.601.7%$320.42m
BNGOBionano Genomics, Inc. -6.78%7.970.0%$281.87m
CRSPCRISPR Therapeutics AG -1.31%117.520.6%$279.23m
EXASEXACT Sciences Corp. -0.41%126.0518.4%$235.07m
SGENSeagen Inc. 0.00%147.935.8%$209.02m
PACBPacific Biosciences of California, Inc. -3.89%29.767.2%$157.45m

Company Profile

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.